Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer

Bladder cancer (BC) is the most common malignancy of the urinary tract. We developed a new and ELISA kit for detecting aberrantly glycosylated integrin α3β1 (AG31) in human urine. We analysed urine samples (n=408) of patients with BC, renal cell carcinoma (RCC), prostate cancer (PC), cystitis, nephr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Di, Zhang, Ruiyun, Chen, Haige, Li, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346044/
https://www.ncbi.nlm.nih.gov/pubmed/32534450
http://dx.doi.org/10.18632/aging.103297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346044/
https://www.ncbi.nlm.nih.gov/pubmed/32534450
http://dx.doi.org/10.18632/aging.103297

Ejemplares similares